AMCR
Amcor plc
Quarterly revenue, EPS, free cash flow, valuation, and Rule of 40 scores for Amcor plc.
Amcor completed the transformational Berry Global merger, creating a global packaging powerhouse. Q2 FY2026 delivered $5.45B in sales (up 68%), $0.86 adjusted EPS (beat), and $55M in synergies at the upper end of guidance. The company is on track for 12-17% EPS growth with $650M total synergies by FY2028. Reverse stock split completed January 2026. GLP-1 weight-loss drug boom is creating new opportunities in nutrition/health packaging. Analysts raised targets to $54-56; Buy ratings persist.
Latest Coverage
Amcor Provides a One-Stop Solution for Fragrances of Ireland's Inis Brand Extension
Delivered comprehensive packaging solution (design to production) for Inis fragrance brand extension; highlights end-to-end capabilities in beauty/personal care packaging.
Amcor Enables Commercialization of Recycle-Ready Packaging for Largest Dairy Cooperative in Canada
Partnered to launch fully recyclable rigid/flexible packaging for dairy products; advances sustainability goals and supports circular economy.
Amcor Price Target Raised to $56 from $48.40 at BofA
BofA and others raised targets post-Q2 beat and synergy execution; Buy ratings persist, citing scale from Berry, margin expansion, and dividend appeal.
Amcor Reports Solid Second Quarter Results and Reaffirms Fiscal 2026 Guidance
Q2 net sales $5.45B (up 68% from Berry acquisition), adjusted EPS $0.86 (up 7%, beat estimates), synergies $55M at upper end; reaffirmed FY2026 EPS $4.00-$4.15.
Amcor Talks GLP-1 Opportunities and Impacts
Discussed packaging implications from GLP-1 drugs driving demand for nutrition/health packaging; integration synergies strong, portfolio optimization progressing post-Berry merger.
Amcor (AMCR) Q2 2026 Earnings Call Transcript and Highlights
Strong EPS growth from synergies (on track for $260M+ FY2026); CEO emphasizes Berry integration success, portfolio optimization, and positioning as global leader in consumer/health packaging.
Earnings release dates
| Quarter | End date | Publication date | Source |
|---|---|---|---|
| 2026 Q2 | 2025-12-31 | 2026-02-03 | Link |
| 2026 Q1 | 2025-09-30 | 2025-10-30 | Link |
| 2025 Q4 | 2025-06-30 | 2025-08-14 | Link |
| 2025 Q3 | 2025-03-31 | 2025-04-30 | Link |
| 2025 Q2 | 2024-12-31 | 2025-02-04 | Link |
| 2025 Q1 | 2024-09-30 | 2024-10-31 | Link |
| 2024 Q4 | 2024-06-30 | 2024-08-15 | Link |
| 2024 Q3 | 2024-03-31 | 2024-04-30 | Link |
| 2024 Q2 | 2023-12-31 | 2024-02-06 | Link |
| 2024 Q1 | 2023-09-30 | 2023-10-31 | Link |
Company History
Key Players
Short interest data unavailable for AMCR.
